Table 4.
Comparison of demographic and clinical characteristics among groups of MSA-C and MSA-P.
| MSA-C (n = 22) |
MSA-P (n = 29) |
p Value | |
|---|---|---|---|
| Age (years) | 63.4 ± 10.8 | 67.0 ± 9.6 | 0.505 |
| Male (%) | 36.3 | 48.3 | 0.569 |
| Disease duration (years) | 4.6 ± 3.3 | 4.3 ± 2.8 | 0.466 |
| MMSE | 27.3 ± 2.7 | 26.4 ± 3.2 | 0.956 |
| LED (mg/day) | 40.9 ± 140.3 | 377.1 ± 326.2 | 0.032 |
| Laxative use (%) | 18.2 | 62.0 | 0.002 |
Data are presented as the mean ± SD. MSA-C, multiple system atrophy, predominant cerebellar ataxia; MSA-P, multiple system atrophy, predominant parkinsonism; LED, levodopa equivalent dose; MMSE, Mini-Mental State Examination.